Navigation Links
Dr. Ken Kaitin, Tufts CSDD, Keynotes Preclinical Conference

BOSTON, Aug. 25, 2011 /PRNewswire/ -- CBI, a division of Advanstar Communications, is pleased to announce that Dr. Ken Kaitin, Director of the Tufts Center for the Study of Drug Development and Research Professor at Tufts University School of Medicine, is the keynote speaker at their Pharma/Bio Forum on Preclinical Development. The conference is being held September 26-27, 2011 at the Hyatt Harborside in Boston, MA. Dr. Kaitin will review today's research and development landscape and discuss how companies are restructuring to maximize efficiency and boost productivity.

Key success factors for many leading pharmaceutical companies include: alliances and partnerships, understanding the challenges of academic-industry relationships and leveraging translational science. Dr. Kaitin will share insight on the changing environment for preclinical development and new models of innovation. Learn more about Dr. Kaitin's keynote presentation here.

The recently announced Pfizer innovation center in Boston is just one example of how pharma plans to increase R&D efficiency and lower expenses by teaming up with local hospitals and academic research institutions for innovative drug discovery and translational R&D. Conference presentations designed specifically for those leading innovation in preclinical development include: Best methods for selecting and contracting with a CRO, understand oversight, management and quality challenges with global outsourcing, how to effectively partner with academic institutions, In-licensing and out-licensing - what both sides need to know.

For more information, please call 800-817-8601 or to view the entire agenda please visit or review the agenda. To apply for a press pass, please contact Lauren Donoghue:

Event Sponsors include Toxikon and MPI Research.

About CBI

A subsidiary of Advanstar Communications, CBI Research, Inc. offers Pharmaceutical and Healthcare conferences that serve senior executives and government officials by providing a unique platform for highly focused content and ideal networking opportunities with senior policy and decision makers. CBI events provide you with concrete, real-life examples that you can begin to apply at your organization immediately for significant impact on costs and revenue. For more information, please visit

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at

Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. 3 Tufts engineering faculty earn prestigious national awards for promising research
2. The Jackson Laboratory and Tufts University Announce New Ph.D. Track in Mammalian Genetics
3. Tufts Launches Institute for Biopharmaceutical Partnerships
4. Teliks Aurora Kinase-VEGFR Dual Inhibitor Program Meets a Preclinical Development Milestone
5. Acologix Presents Preclinical Data on Cartilage Regeneration by AC-100 at the 30th ASBMR Annual Meeting
6. Enobia Pharma Presents PreClinical Data Showing ENB-0040 Significantly Improved Survival and Healed Skeletal Manifestations of Severe Hypophosphatasia in Mice
7. Tengion Scientists Publish Positive Preclinical Findings With Neo-Organ Demonstrating Long-term Durability and Growth With Skeletal Maturation
8. Covance Decides to Pursue Its Original Preclinical Strategy in China
9. Positive Preclinical Data on Cell Therapy for Spinal Disc Repair Presented at 23rd Annual Meeting of the North American Spine Society
10. Senescos Preclinical Multiple Myeloma Data to be Presented at the 20th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
11. NanoBio to Announce Key Clinical and Preclinical Data in Nine Presentations at ICAAC/IDSA 2008
Post Your Comments:
(Date:11/24/2015)... LUMPUR, Malaysia , Nov. 24, 2015 /PRNewswire/ ... global contract research organisation (CRO) market. The trend ... result in lower margins but higher volume share ... increased capacity and scale, however, margins in the ... Research Organisation (CRO) Market ( ), ...
(Date:11/24/2015)... 2015 /CNW/ - iCo Therapeutics ("iCo" or "the Company") ... for the quarter ended September 30, 2015. Amounts, ... and presented under International Financial Reporting Standards ("IFRS"). ... said Andrew Rae , President & CEO ... not only value enriching for this clinical program, ...
(Date:11/24/2015)...  Clintrax Global, Inc., a worldwide provider of clinical research services ... that the company has set a new quarterly earnings record in ... growth posted for Q3 of 2014 to Q3 of 2015.   ... , with the establishment of an Asia-Pacific ... United Kingdom and Mexico , ...
(Date:11/24/2015)... -- SHPG ) announced today that Jeff Poulton ... th Annual Healthcare Conference in New York City ... EST (1:30 p.m. GMT). --> SHPG ) announced today ... the Piper Jaffray 27 th Annual Healthcare Conference in ... 2015, at 8:30 a.m. EST (1:30 p.m. GMT). --> ...
Breaking Biology Technology:
(Date:11/18/2015)... , November 18, 2015 ... has published a new market report titled  Gesture Recognition ... and Forecast, 2015 - 2021. According to the report, the global ... and is anticipated to reach US$29.1 bn by 2021, ... North America dominated the ...
(Date:11/16/2015)... 2015  Synaptics Inc. (NASDAQ: SYNA ), ... announced expansion of its TDDI product portfolio with ... and display driver integration (TDDI) solutions designed to ... TDDI products add to the previously-announced TD4300 ... resolution), and TD4322 (FHD resolution) solutions. All four ...
(Date:11/10/2015)... 2015  In this report, the biomarkers ... product, type, application, disease indication, and geography. ... are consumables, services, software. The type segments ... efficacy biomarkers, and validation biomarkers. The applications ... development, drug discovery and development, personalized medicine, ...
Breaking Biology News(10 mins):